2275 related articles for article (PubMed ID: 7868768)
1. Prognostic evaluation of cutaneous malignant melanoma based on the pTNM classification.
Sugihara T; Yoshida T; Kokubu I; Chiba O; Ohura T; Ohkawara A
J Dermatol; 1994 Dec; 21(12):953-9. PubMed ID: 7868768
[TBL] [Abstract][Full Text] [Related]
2. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.
Ingkaninanda P; Visessiri Y; Rutnin S
J Med Assoc Thai; 2015 Aug; 98(8):820-7. PubMed ID: 26437541
[TBL] [Abstract][Full Text] [Related]
4. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
5. Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical Stage I.
Johnson OK; Emrich LJ; Karakousis CP; Rao U; Greco WR
Cancer; 1985 Mar; 55(5):1107-17. PubMed ID: 3967194
[TBL] [Abstract][Full Text] [Related]
6. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification.
Büttner P; Garbe C; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
Cancer; 1995 May; 75(10):2499-2506. PubMed ID: 7736394
[TBL] [Abstract][Full Text] [Related]
8. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
9. Comparison Among Clark's, Breslow's, and TNM classifications for cutaneous head and neck malignant melanoma.
Morselli P; Masciotra L; Pinto V; Zollino I; Brunelli G; Carinci F
J Craniofac Surg; 2007 Nov; 18(6):1353-8. PubMed ID: 17993881
[TBL] [Abstract][Full Text] [Related]
10. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
[TBL] [Abstract][Full Text] [Related]
11. [Results of treatment of malignant melanoma--a computer analysis of 772 patients].
Seebacher C; Steinert W; Küster P; Koch R
Dermatol Monatsschr; 1990; 176(5-6):337-44. PubMed ID: 2227051
[TBL] [Abstract][Full Text] [Related]
12. The importance of anatomic site in prognosis in patients with cutaneous melanoma.
Wong JH; Wanek L; Chang LJ; Goradia T; Morton DL
Arch Surg; 1991 Apr; 126(4):486-9. PubMed ID: 2009064
[TBL] [Abstract][Full Text] [Related]
13. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291
[TBL] [Abstract][Full Text] [Related]
14. Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.
Søndergaard K
Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):49-55. PubMed ID: 3984735
[TBL] [Abstract][Full Text] [Related]
15. Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage).
Wanebo HJ; Woodruff J; Fortner JG
Cancer; 1975 Mar; 35(3):666-76. PubMed ID: 1111935
[TBL] [Abstract][Full Text] [Related]
16. Difficulties encountered in the application of Clark classification and the Breslow thickness measurement in cutaneous malignant melanoma.
Prade M; Sancho-Garnier H; Cesarini JP; Cochran A
Int J Cancer; 1980 Aug; 26(2):159-63. PubMed ID: 7009438
[TBL] [Abstract][Full Text] [Related]
17. [Stage I malignant melanoma of the skin. Prognostic value of thickness and level (author's transl)].
Palangié A; Lassau F; Moreau T; Noury-Duperrat G; Cottenot F
Nouv Presse Med; 1981 Jun; 10(28):2337-41. PubMed ID: 7267338
[TBL] [Abstract][Full Text] [Related]
18. [Comparative analysis of narcosis and local anesthesia in surgery of malignant melanoma of the skin].
Seebacher C; Heubaum F; Küster P; Steinert W; Koch R
Hautarzt; 1990 Mar; 41(3):137-41. PubMed ID: 2345097
[TBL] [Abstract][Full Text] [Related]
19. Identifying predictive factors in melanoma progression.
Dabrowska DM; Elashoff RM; Ho W; Morton DL
Oncol Rep; 1998; 5(3):569-75. PubMed ID: 9538154
[TBL] [Abstract][Full Text] [Related]
20. Malignant melanoma in children: its management and prognosis.
Rao BN; Hayes FA; Pratt CB; Fleming ID; Kumar AP; Lobe T; Dilawari R; Meyer W; Parham D; Custer MD
J Pediatr Surg; 1990 Feb; 25(2):198-203. PubMed ID: 2303989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]